Skip to content

Clinical trials

Terminated Dementia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Status: Terminated Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20132
20143
20151
20162
20172
20181
20201
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
FORUM Pharmaceuticals Inc3
AstraZeneca2
Janssen Research & Development, LLC2
Center for Eye Research Australia1
Eisai Co., Ltd.1
Genentech, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
Inmune Bio, Inc.1
TauRx Therapeutics Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease15
Dementia15
Brain Diseases7
Central Nervous System Diseases5
Mental Disorders5
Nervous System Diseases5
Neurocognitive Disorders5
Neurodegenerative Diseases5
Tauopathies4
Cognitive Dysfunction3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.